Agentic AI is arriving in clinical operations with genuine capability to absorb administrative work, but the organizations ...

AI platforms that absorb trial data reconciliation could compress operations toward a small, accountable team.

Growing investment in agentic AI and workflow modernization signals that the industry is finally starting to treat payment ...

In this video interview, Patrick Mizer, chief technology officer at Ledger Run, describes how agentic AI is being applied to ...

AI is reshaping clinical research faster than any technology before it; but for sponsors and CROs, adoption without GxP-grade ...

How connected workflows can improve visibility across participant activity, treatment allocation, eCOA compliance, and supply ...

In today's ACT Brief, we examine where agentic AI delivers immediate wins in site payments, how botanical therapies can earn ...

He closed by connecting payment infrastructure directly to the broader site access problem, noting that with 80% of sites operating on six months or less of cash, the urgency is clear—and that the ...

AI is reshaping clinical research faster than any technology before it; but for sponsors and CROs, adoption without GxP-grade governance, validation, and human oversight isn't a strategy. It's a risk.

In a recent video interview with Applied Clinical Trials, Patrick Mizer, chief technology officer at Ledger Run, discussed how payment reliability has quietly become one of the mo ...

In this episode of Beyond Compliance, Otis Johnson, PhD, MPA, founder and principal consultant at Vantix Operations, speaks with Joel Stanley, CEO of AJNA BioSciences, about why botanical therapies ...

Inspection readiness reflects how a program was actually run throughout its lifecycle, not what can be assembled at the end, making pre-submission remediation itself a signal of absent oversight ...